Acrivon Therapeutics Inc. Common Stock ACRV · Stock Open Acrivon Therapeutics Inc. Common Stock in new tab
Acrivon Therapeutics Inc. Common Stock Analysis (ACRV)
Is Acrivon Therapeutics Inc. Common Stock a good investment? Acrivon Therapeutics Inc. Common Stock (ACRV) is currently trading at 2.01 USD. Market analysts have a consensus price target of 11.50 USD. This suggests a potential upside from current levels.
Earnings Schedule: Acrivon Therapeutics Inc. Common Stock is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -1.64.
Investor FAQ
Does Acrivon Therapeutics Inc. Common Stock pay a dividend?
No, it does not currently pay a dividend.
What asset class is Acrivon Therapeutics Inc. Common Stock?
Acrivon Therapeutics Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of -1.88.
Company Profile
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
Community Discussion